Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer.
Mansoori-Kermani A, Khalighi S, Akbarzadeh I, Niavol FR, Motasadizadeh H, Mahdieh A, Jahed V, Abdinezhad M, Rahbariasr N, Hosseini M, Ahmadkhani N, Panahi B, Fatahi Y, Mozafari M, Kumar AP, Mostafavi E.
Mansoori-Kermani A, et al. Among authors: mahdieh a.
Mater Today Bio. 2022 Jul 6;16:100349. doi: 10.1016/j.mtbio.2022.100349. eCollection 2022 Dec.
Mater Today Bio. 2022.
PMID: 35875198
Free PMC article.